Get started
Author

Qi Tang

Observed name: Q. Tang
OpenAlex ID: A5121069173
Efficacy of radiotherapy combined with systemic therapy for retroperitoneal lymph node metastasis in upper tract urothelial carcinoma(UTUC) patients after radical nephroureterectomy
2025 · Xiaoying Li, Xiaoying Li, et al. · World Journal of Surgical Oncology · 2
PDF
Preliminary results of a phase II study to evaluate the efficacy and safety of disitamab vedotin (RC48-ADC) in combination with radiotherapy for adjuvant therapy in upper tract urothelial carcinoma.
2025 · Zihao Tao, Xuanjun Guo, et al. · Journal of Clinical Oncology · 2
PDF
Noninvasive Evaluation of HER2 Expression and Heterogeneity in Urothelial Carcinoma on 68Ga-HER2-affibody PET/CT
2025 · Zihao Tao, Xueqi Chen, et al. · Clinical Nuclear Medicine · 1
Patient-derived tumour-immune organoids as functional biomarkers of checkpoint-inhibitor response: a systematic review and exploratory meta-analysis
2026 · Chenghao Tan, Bohao Wang, et al. · medRxiv
Longitudinal utDNA dynamics predict recurrence risk in upper tract urothelial carcinoma: A prospective cohort study
2026 · Wei Zuo, Qi Tang, et al. · Urologic Oncology Seminars and Original Investigations
Adjuvant pembrolizumab in clear cell renal cell carcinoma with high recurrence risk: A multicenter real-world study.
2026 · Liangyou Gu, Yicong Du, et al. · Journal of Clinical Oncology
Efficacy and safety of RC48 alone or combined with PD-1 inhibitors in high-risk non-muscle invasive bladder cancer
2026 · Xuanjun Guo, Shuoyu Wang, et al. · Scientific Reports
PDF
496P PROspect: A multi-center, single-arm, prospective study to investigate the efficacy and safety of olaparib monotherapy in newly diagnosed mCRPC patients who progressed on NHA with HRR gene mutation
2025 · H. Liu, Y. He, et al. · Annals of Oncology
Works count: 8
Citation count: 5
H-index: 2
I10-index:
Year
Topic
Type